Advantage Alpha Capital Partners LP Arrowhead Pharmaceuticals, Inc. Transaction History
Advantage Alpha Capital Partners LP
- $337 Million
- Q2 2025
A detailed history of Advantage Alpha Capital Partners LP transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Advantage Alpha Capital Partners LP holds 12,938 shares of ARWR stock, worth $447,654. This represents 0.06% of its overall portfolio holdings.
Number of Shares
12,938Holding current value
$447,654% of portfolio
0.06%Shares
1 transactions
Others Institutions Holding ARWR
# of Institutions
321Shares Held
99.1MCall Options Held
444KPut Options Held
568K-
Black Rock Inc. New York, NY15.7MShares$543 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.5MShares$537 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY10.6MShares$367 Million3.05% of portfolio
-
State Street Corp Boston, MA6.37MShares$220 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$181 Million1.65% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $3.66B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...